Terms: = Leukemia AND FIP1L1, DKFZp586K0717, 81608, ENSG00000145216, Q6UN15 AND Prognosis
16 results:
1. Lab tests for MPN.
Moncada A; Pancrazzi A
Int Rev Cell Mol Biol; 2022; 366():187-220. PubMed ID: 35153004
[TBL] [Abstract] [Full Text] [Related]
2. [Hypereosinophilic syndromes].
Groh M; Lefèvre G; Ackermann F; Étienne N; Kahn JE
Rev Prat; 2019 Sep; 69(7):767-773. PubMed ID: 32233322
[TBL] [Abstract] [Full Text] [Related]
3. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract] [Full Text] [Related]
4. Long-term outcomes of imatinib in patients with fip1l1/ PDGFRA associated chronic eosinophilic leukemia: experience of a single center in China.
Qu SQ; Qin TJ; Xu ZF; Zhang Y; Ai XF; Li B; Zhang HL; Fang LW; Pan LJ; Hu NB; Xiao ZJ
Oncotarget; 2016 May; 7(22):33229-36. PubMed ID: 27120808
[TBL] [Abstract] [Full Text] [Related]
5. Hypereosinophilic Syndrome.
Curtis C; Ogbogu P
Clin Rev Allergy Immunol; 2016 Apr; 50(2):240-51. PubMed ID: 26475367
[TBL] [Abstract] [Full Text] [Related]
6. No asthma, no parasites is a rare type of leukemia: chronic myeloid neoplasm with eosinophilia and abnormality of platelet-derived growth factor receptor alpha.
Santiago-Casiano M; Alemán JR; Matos-Fernández NA; Cáceres-Perkins W; De La Paz M
Bol Asoc Med P R; 2012; 104(3):41-6. PubMed ID: 23156891
[TBL] [Abstract] [Full Text] [Related]
7. [New insights into hypereosinophilic syndromes].
Bletry O; Kahn JE; Ackermann F; Charles P; Legrand F
Bull Acad Natl Med; 2010 Mar; 194(3):547-59; discussion 559-60. PubMed ID: 21171248
[TBL] [Abstract] [Full Text] [Related]
8. Hypereosinophilic syndrome and proliferative diseases.
Ionescu MA; Wang L; Janin A
Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
[TBL] [Abstract] [Full Text] [Related]
9. Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and fip1l1-PDGFRA correlates.
Tefferi A; Levine RL; Lim KH; Abdel-Wahab O; Lasho TL; Patel J; Finke CM; Mullally A; Li CY; Pardanani A; Gilliland DG
Leukemia; 2009 May; 23(5):900-4. PubMed ID: 19262599
[TBL] [Abstract] [Full Text] [Related]
10. Five years since the discovery of fip1l1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.
Gotlib J; Cools J
Leukemia; 2008 Nov; 22(11):1999-2010. PubMed ID: 18843283
[TBL] [Abstract] [Full Text] [Related]
11. Imatinib: new indication. New indications, but not robust evidence.
Prescrire Int; 2008 Jun; 17(95):91-4. PubMed ID: 18623899
[TBL] [Abstract] [Full Text] [Related]
12. Oral mucosa lesions in hypereosinophilic syndrome--an update.
Ionescu MA; Murata H; Janin A
Oral Dis; 2008 Mar; 14(2):115-22. PubMed ID: 18194138
[TBL] [Abstract] [Full Text] [Related]
13. The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers.
Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
Ann Hematol; 2008 Jan; 87(1):1-10. PubMed ID: 17938925
[TBL] [Abstract] [Full Text] [Related]
14. [Diagnostic algorithm in chronic myeloproliferative diseases (CMPD)].
Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
Med Klin (Munich); 2007 Sep; 102(9):770-7. PubMed ID: 17879017
[TBL] [Abstract] [Full Text] [Related]
15. A case of fip1l1-PDGFRA-positive chronic eosinophilic leukemia with a rare fip1l1 breakpoint.
Lambert F; Heimann P; Herens C; Chariot A; Bours V
J Mol Diagn; 2007 Jul; 9(3):414-9. PubMed ID: 17591942
[TBL] [Abstract] [Full Text] [Related]
16. Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants.
Roufosse F; Goldman M; Cogan E
Semin Respir Crit Care Med; 2006 Apr; 27(2):158-70. PubMed ID: 16612767
[TBL] [Abstract] [Full Text] [Related]
